
	Prior to joining Genocea, Mr. Poole was senior vice president of finance for pipeline and technical operations, leading finance support for Shire&#39;s global business development, R&amp;D and technical operations activities. Mr. Poole previously served for three years as divisional CFO of Shire HGT, Shire&#39;s $1.5 billion rare disease division. He began his career in the UK in investment banking at UBS Warburg and ING Barings and also worked as an investment manager for Avanti Capital Plc, a UK private equity investment firm. Mr. Poole has a MBA from London Business School and a BSc in biological sciences from Durham University in the UK.
